Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment.
Autor: | Elmetwalli A; Department of Clinical Trial Research Unit and Drug Discovery, Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. dr.prof2011@gmail.com.; Microbiology Division, Higher Technological Institute of Applied Health Sciences, Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. dr.prof2011@gmail.com., Abdel-Monem MO; Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt., El-Far AH; Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, Egypt., Ghaith GS; Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt., Albalawi NAN; Department of Nursing, Al Hadithah General Hospital, Al Qurayyat, Saudi Arabia., Hassan J; Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt., Ismail NF; Health Information Management Program, Biochemistry, Faculty of Health Science Technology, Borg El Arab Technological University, Alexandria, Egypt., El-Sewedy T; Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt., Alnamshan MM; Biology Department, College of Science, Imam Abdulrahman Bin Faisal University, 31441, Dammam, Saudi Arabia., ALaqeel NK; Biology Department, College of Science, Imam Abdulrahman Bin Faisal University, 31441, Dammam, Saudi Arabia., Al-Dhuayan IS; Biology Department, College of Science, Imam Abdulrahman Bin Faisal University, 31441, Dammam, Saudi Arabia., Hassan MG; Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | Medical oncology (Northwood, London, England) [Med Oncol] 2024 Apr 04; Vol. 41 (5), pp. 106. Date of Electronic Publication: 2024 Apr 04. |
DOI: | 10.1007/s12032-024-02330-8 |
Abstrakt: | Recent advances in nanotechnology have offered novel ways to combat cancer. By utilizing the reducing capabilities of Lactobacillus acidophilus, silver nanoparticles (AgNPs) are synthesized. The anti-cancer properties of AgNPs have been demonstrated in previous studies against several cancer cell lines; it has been hypothesized that these compounds might inhibit AMPK/mTOR signalling and BCL-2 expression. Consequently, the current research used both in vitro and in silico approaches to study whether Lactobacillus acidophilus AgNPs could inhibit cell proliferation autophagy and promote apoptosis in HepG2 cells. The isolated strain was identified as Lactobacillus acidophilus strain RBIM based on 16 s rRNA gene analysis. Based on our research findings, it has been observed that this particular strain can generate increased quantities of AgNPs when subjected to optimal growing conditions. The presence of silanols, carboxylates, phosphonates, and siloxanes on the surface of AgNPs was confirmed using FTIR analysis. AgNPs were configured using UV-visible spectroscopy at 425 nm. In contrast, it was observed that apoptotic cells exhibited orange-coloured bodies due to cellular shrinkage and blebbing initiated by AgNP treatment, compared to non-apoptotic cells. It is worth mentioning that AgNPs exhibited remarkable selectivity in inducing cell death, specifically in HepG2 cells, unlike normal WI-38 cells. The half-maximum inhibitory concentration (IC (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |